RNA Sequencing Market Report 2025 (Global Edition)

Global RNA Sequencing Market Report 2024 Market Size Split by Product Type (Instruments, Reagents and Kits, Software), by Technology (Single Molecule Based Sequencing, Sequence by Synthesis Technology...

RNA Sequencing Market Report Description

We have various report editions of RNA Sequencing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

RNA Sequencing Market Insights Video

Competitive Landscape of the RNA Sequencing Market

In the competitive environment of the RNA Sequencing Market, numerous important competitors are setting the pace with breakthrough technologies and comprehensive solutions. These firms offer a variety of RNA sequencing technologies, reagents, and analytic tools to meet the different demands of academics and physicians. Furthermore, emergent firms working on novel sequencing technologies and bioinformatics tools are influencing the competitive landscape. The market is distinguished by continual R&D initiatives, strategic alliances, and a focus on improving sequencing accuracy, speed, and cost-effectiveness in order to maintain a competitive edge in the rapidly changing RNA sequencing landscape.

April 2024, in Lausanne, Switzerland. NewBiologix, a technology innovation business focusing on tackling difficulties in gene therapy production, has announced its new platform for NGS and optical mapping. This comprehensive collection of services is expected to provide the biopharmaceutical industry with a convenient and efficient genomic analysis solution. (Source: https://www.biopole.ch/newbiologix-launches-next-generation-sequencing/) December 2023, Illumina signed a Memorandum of Understanding with the African Society for Laboratory Medicine to utilize genomics in Africa to battle infectious diseases. (Source: https://www.illumina.com/company/about-us/corporate-social-responsibility/news-feed.html?mid=1211846)

Top Companies Market Share in RNA Sequencing Industry: (In no particular order of Rank)

• Agilent Technologies
• Inc.
• Bio-Rad Laboratories
• Inc.
• BGI
• F. Hoffmann La-Roche AG
• Fluidigm Corporation
• Illumina
• Inc.
• Lexogen GmbH
• Oxford Nanopore Technologies
• Pacific Biosciences
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• Becton
• Dickinson and Company
• Dolomite Bio
• Takara Bio Inc.
• Merck KGaA.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the RNA Sequencing Market

Which Region Dominates the RNA Sequencing Market in 2024?

According to Cognitive Market Research, North America is expected to dominate this market in 2023, with the biggest market share compared to other regions. The existence of several next generation sequencing players and clinical laboratories that use next generation sequencing to perform genetic testing in the region is the primary driver of the regional market. Aside from that, the introduction of new goods by key players, as well as technological advancements in existing items, will boost the regional industry over the projection period.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is predicted to have a market share in the communications software market throughout the forecast period. The region's market growth can be attributed to the presence of various key players offering services such as digital PCR solutions and next-generation sequencing, such as BGI Genomics. NGS service providers include First BASE Laboratories Sdn Bhd, Macrogen Asia-Pacific Pte Ltd., and others. These big players have a diverse portfolio that can meet nearly every customer need.

 

The current report Scope analyzes RNA Sequencing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America RNA Sequencing

According to Cognitive Market Research, the global RNA Sequencing market size was estimated at USD 3895.5 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1558.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.8% from 2024 to 2031. The North America RNA sequencing market is a prime and dynamic region of the life sciences industry. North America, mainly the United States, holds the innovation and research platform in developing and commercializing these RNA sequencing technologies. Important drivers of the North American regional market are the high presence of biotechnology and pharmaceutical companies, academic institutes engaged in research, and government initiatives in genomics research. Applications of RNA sequencing are very broad in North America: diagnostics, drug discovery, personalized medicine, and agricultural research. The infrastructure for conducting genomic studies is already well developed in the region; bioinformatics capabilities are advanced, and there is also a ready workforce skilled in the fields of genomics and molecular biology.

Europe RNA Sequencing

According to Cognitive Market Research, the global RNA Sequencing market size was estimated at USD 3895.5 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 1168.65 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.1% from 2024 to 2031. The European RNA Sequencing market is a significant region of Europe's life sciences industry. Europe offers a large number of research organizations, biotechnology businesses, and academic centers that promote innovation and progress in RNA sequencing technologies. Countries such as the United Kingdom, Germany, France, and Switzerland are significant players in the European RNA sequencing business. In Europe, RNA sequencing is widely employed in a variety of applications including diagnostics, drug development, agriculture, and customized medicine. The region benefits from a collaborative research environment, government financing for genomics research, and an emphasis on precision medicine programs.

Asia Pacific RNA Sequencing

According to Cognitive Market Research, the global RNA Sequencing market size was estimated at USD 3895.5 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 895.97 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.6% from 2024 to 2031. The Asia Pacific RNA sequencing market represents the faster-growing segment of the life sciences industry in the Asia-Pacific region. Research in genomics and development in biotechnology is currently led by China, Japan, India, South Korea, and Australia, and this has served as a backstay for the adoption of RNA sequencing technologies across different applications. The RNA sequencing market in the Asia Pacific comprises some players that are already established, while others are still emerging, with their business activities focused on developing sequencing platforms, bioinformatics solutions, and services to suit diverse requirements by researchers and healthcare professionals. Industry-academia-government collaborations, coupled with rapidly evolving genomics research in the region, pave the way for growth and innovation in the RNA sequencing market across Asia Pacific.

South America RNA Sequencing

According to Cognitive Market Research, the global RNA Sequencing market size was estimated at USD 3895.5 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 194.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 20.0% from 2024 to 2031. The Latin American RNA Sequencing market is a growing segment of the Latin American life sciences industry. Latin American countries such as Brazil, Mexico, Argentina, and Chile are increasing their investments in genomics research and biotechnology, which is pushing the regional use of RNA sequencing technologies. The Latin American RNA Sequencing market is characterized by a mix of local and foreign companies that provide sequencing platforms, bioinformatics tools, and services targeted to the specific demands of Latin American researchers and healthcare practitioners. Government initiatives supporting genomics research, increased spending in healthcare infrastructure, and a focus on tackling regional health concerns all help to drive the RNA sequencing market in Latin America.

Middle East and Africa RNA Sequencing

According to Cognitive Market Research, the global RNA Sequencing market size was estimated at USD 3895.5 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 77.91 million in 2024 and will grow at a compound annual growth rate (CAGR) of 20.3% from 2024 to 2031. The Middle East and Africa RNA sequencing market is a growing industry of the life sciences sector in this region. According to the market information, countries like United Arab Emirates, South Africa, Nigeria, and Saudi Arabia are massively investing in genomics research and biotechnology, thereby fueling the adoption of RNA sequencing technologies. In the Middle East and Africa, applications of RNA sequencing are in diagnostics, drug discovery, and agriculture, and it also comprises research studies of infectious diseases and genetic disorders common to the region. Increasing interest in personalized medicine, biotechnological developments, and active collaboration between research institutions and industrial players work to the benefit of the market.

RNA Sequencing Market Analysis

RNA Sequencing Market Product Type Segment Analysis

According to Cognitive Market Research, Instruments is the dominant category in the RNA Sequencing Market. Instruments such as sequencers and sample preparation equipment are critical components of RNA sequencing workflows, accounting for a major amount of market revenue. These equipment are critical for producing high-quality sequencing data and are in high demand among academic institutes, biotechnology companies, and healthcare facilities that conduct RNA sequencing studies

The Software sector is the fastest growing in the RNA Sequencing Market. As the volume and complexity of RNA sequencing data grows, so does the demand for advanced bioinformatics tools and software solutions for analyzing, visualizing, and interpreting it. Software is essential for processing raw sequencing data, finding gene expression patterns, discovering mutations, and doing pathway analysis. The development of user-friendly, efficient, and powerful software platforms specifically designed for RNA sequencing analysis is propelling this market segment forward.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of RNA Sequencing Industry. Request a Free Sample PDF!

RNA Sequencing Market Technology Segment Analysis

According to Cognitive Market Research, Sequencing by synthesis is the most popular category in the NGS industry because it is highly accurate, conveniently scalable, and reasonably priced. SBS technology is the most widely used method for platforms such as Illumina's sequencing devices. SBS is used for a variety of purposes and is widely regarded as the most effective approach for whole genome sequencing, exome sequencing, and RNA sequencing. It has increased its dominance by continuous innovation and application in the clinical and scientific arenas, resulting in greater market share.

The nanopore sequencing sector is predicted to have the greatest CAGR in the NGS industry. These properties include real-time sequencing, larger read lengths, and portability, making this technology highly applicable to a wide range of applications, including field samples and point-of-care. Companies such as Oxford Nanopore Technologies are now operating in this market and are constantly developing and enhancing their technology.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

RNA Sequencing Workflow Segment Analysis

Workflow Segment Analysis

According to Cognitive Market Research, Library Preparation is the dominant section of the RNA Sequencing Market. RNA fragmentation, cDNA synthesis, and adaptor ligation are examples of procedures used in library preparation to convert RNA samples into a sequencing-ready state. Library preparation kits and techniques are critical for achieving accurate and repeatable sequencing findings, making this segment an important part of the RNA sequencing workflow and a substantial source of market revenue.

The RNA Sequencing Market's fastest-growing sector is Data Analysis and Management. As the number and complexity of RNA sequencing data generated by experiments increase, so does the requirement for advanced bioinformatics tools and software for data analysis, interpretation, and administration. Efficient data analysis pipelines, visualization tools, and data management solutions are becoming increasingly critical in extracting useful insights from RNA sequencing data, which is driving market expansion in this category

• Sample Isolation and Extraction
• Sample Enrichment
• Library Preparation
• Sequencing
• Data Analysis and Management

RNA Sequencing End-User Segment Analysis

End-User Segment Analysis

According to Cognitive Market Research, The research and academic sectors dominate the next-generation sequencing (NGS) market. They are among the largest NGS users for research, genomics, and huge population sequencing initiatives. Increased government financing for academic research programs, combined with the collaborative nature of scientific work, creates a strong demand for NGS systems. This category is reliant on government aid and institutional support, and so accounts for the majority of the market's revenue and consumption.

The Life-sciences and Biotechnology Companies is regarded as the most dynamic segment of the NGS market. The use of Next Generation Sequencing in drug discovery, development, and new therapies, including personalized medicine, is increasing as a result of the demand for specificity in the creation of related therapeutic interventions. These companies employ it for biomarker identification, companion diagnostic tests, and clinical research, all of which contribute to the segment's growth. Because of the ability of NGS to shorten the development time of novel pharmaceuticals and treatments, as well as investments in biotechnology, this area is expected to grow at the fastest rate in the near future..

• Biopharmaceuticals
• Diagnostic Centers
• Life-sciences and Biotechnology Companies
• Research and Academia

RNA Sequencing Applications Segment Analysis

Applications Segment Analysis

According to Cognitive Market Research, Diagnostics accounts for the greatest market share in the RNA Sequencing Market. The use of RNA sequencing in diagnostics, including illness profiling, biomarker development, and personalized medicine applications, has grown significantly. RNA sequencing technologies provide valuable insights into gene expression patterns and molecular signatures associated with various disorders, resulting in increased acceptance of RNA sequencing in diagnostic applications and a significant market share in the healthcare industry.

Drug Discovery is the fastest growing section of the RNA Sequencing Market. RNA sequencing is important in drug discovery and development because it allows researchers to identify prospective drug targets, better understand disease mechanisms, and evaluate treatment responses at the molecular level. The use of RNA sequencing in drug discovery opens up opportunities for precision medicine, target validation, and therapeutic development, resulting in the market segment's rapid growth.

• Diagnostics
• Drug Discovery
• Translational Medicine
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion